Invention Grant
- Patent Title: Crystalline 4-(3S-(1R-(1-napthyl)ethylamino)pyrrolidin-1-yl)phenylacetic acid
-
Application No.: US14916859Application Date: 2014-09-05
-
Publication No.: US09643920B2Publication Date: 2017-05-09
- Inventor: Hiroshi Miyazaki , Takao Komasaka , Joji Tsurumoto , Takeshi Uemura , Yuuji Morita
- Applicant: MITSUBISHI TANABE PHARMA CORPORATION
- Applicant Address: JP Osaka
- Assignee: MITSUBISHI TANABE PHARMA CORPORATION
- Current Assignee: MITSUBISHI TANABE PHARMA CORPORATION
- Current Assignee Address: JP Osaka
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: WOPCT/JP2013/073954 20130905
- International Application: PCT/JP2014/073426 WO 20140905
- International Announcement: WO2015/034031 WO 20150312
- Main IPC: C07D207/50
- IPC: C07D207/50 ; C07D207/14
Abstract:
The present invention provides crystal forms A and B of 4-(3S-(1R-(1-naphthyl)ethylamino)pyrrolidin-1-yl)phenylacetic acid having excellent stability and use as pharmaceutical ingredients. The present invention also provides industrially advantageous processes for producing these crystalline compounds.
Public/Granted literature
- US20160200679A1 NOVEL CRYSTALLINE ARYLALKYLAMINE COMPOUND AND PROCESS FOR PRODUCING THE SAME Public/Granted day:2016-07-14
Information query
